
Access & Affordability
© 2021 Teva Respiratory, LLC. CIQ-41277 03/2021
HCP=healthcare professional; IV=intravenous.
*Monitor patients during the infusion and for an appropriate time afterward.1
Consider ordering a complete blood count with differential diagnosis
for your patients with severe asthma.3
REFERENCES: 1. CINQAIR Prescribing Information. West Chester, PA. Teva Respiratory, LLC. 2. Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83-87. 3. Data on file (clinical study report: a 12-month, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of reslizumab [3.0 mg/kg] in the reduction of clinical asthma exacerbations in patients [12-75 years of age] with eosinophilic asthma. Study C38072/3083). Parsippany, NJ. Teva Respiratory, LLC. February 2015.